Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 14 of about 14 for MERCK & CO., INC.�
Company Exchange Symbol Last price Quote change Market cap
Ligand Pharmaceuticals Inc. NASDAQ LGND 56.59 -0.44 (-0.77%) 1.11B
Ligand Pharmaceuticals Incorporated (Ligand) is a biotechnology company that operates with a business model focused on developing or acquiring assets.
Merck & Co., Inc. NYSE MRK 61.29 -0.80 (-1.29%) 174.73B
Merck & Co., Inc. is a health care company that offers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, ...
Enzon Pharmaceuticals Inc NASDAQ ENZN 0.970 -0.030 (-2.95%) 42.71M
Enzon Pharmaceuticals, Inc. (Enzon) is a biotechnology company. The Company's drug development programs utilize two platforms: Customized PEGylation Linker ...
Xenon Pharmaceuticals Inc NASDAQ XENE 16.78 -0.46 (-2.70%) 237.90M
(Teva) (through its subsidiary, Ivax International GmbH), Genentech, Inc. ( Genentech), and Merck & Co., Inc. (Merck) (through its affiliate, Essex Chemie ...
Alkermes Plc NASDAQ ALKS 72.14 -0.05 (-0.08%) 10.55B
Alkermes Public Limited Company is an integrated, global biopharmaceutical company. The Company has a portfolio of more than 20 commercial drug products and ...
Par Pharmaceutical Companies, Inc. NYSE PRX 0.0000
Par Pharmaceutical Companies, Inc. is a holding company that, principally through its wholly owned operating subsidiary, Par Pharmaceutical, Inc., ...
Nektar Therapeutics NASDAQ NKTR 14.94 -0.12 (-0.80%) 1.92B
Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms.
MERCK AND CO INC EPA MRK 54.35 +0.45 (0.83%)
XENON PHARMACEUTICALS FRA XP0 15.01 +0.07 (0.44%)
ENZON PHARMACEUT. DL-,01 FRA EZ1 0.850 -0.016 (-1.85%)
PAR PHARMACEUT. DL-,01 FRA PZJ 37.93
ALKERMES PLC DL-,01 FRA 8AK 63.29 -0.21 (-0.33%)
NEKTAR THERAPEUTICS FRA ITH 13.10 +0.35 (2.79%)
MERCK & CO INC CEDEAR (10 REP 1 USD0.50) BCBA MRK 0.0000